Internal Medicine, Cardiovascular Disease · Webster, TX
NPI
1225072507
Since 2006
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
530 Orchard St
Webster, TX, 77598
Phone (281) 338-4004
Groups this clinician bills Medicare through
Medicare paid, 2024
$438K
5,049 services
Medicare patients, 2024
1,095
Average age 76
Drug cost, 2024
$2.0M
7,653 prescriptions
Company payments, 2025
$2,189
From 20 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Gerard Abreo was code 99214 (office e&m - established), 1,167 times for 723 patients. In total Gerard Abreo billed 5,049 services in 60 codes, and Medicare paid $438K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-01-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,167 | 723 | $93.48 | $109K |
| 99232 Hospital E&M - Subsequent | Facility | 801 | 172 | $60.78 | $49K |
| 93000 Electrocardiogram | Office | 556 | 529 | $10.64 | $5,916 |
| 93010 Electrocardiogram | Facility | 245 | 160 | $6.31 | $1,546 |
| J2785 Injection, regadenoson, 0.1 mg | Office | 244 | 61 | $3.53 | $862 |
| 93306 Echocardiography (TTE/TEE) | Office | 224 | 213 | $150.10 | $34K |
| 93306 Echocardiography (TTE/TEE) | Facility | 182 | 165 | $53.04 | $9,653 |
| 93296 External Electrocardiographic Monitoring | Office | 145 | 58 | $15.23 | $2,208 |
| 99204 Office E&M - New | Office | 120 | 120 | $122.27 | $15K |
| 93294 External Electrocardiographic Monitoring | Office | 116 | 46 | $21.63 | $2,509 |
| 99222 Hospital E&M - Initial | Facility | 113 | 103 | $101.90 | $12K |
| 85610 Clinical Chemistry | Office | 106 | 11 | $4.20 | $445 |
| 93015 Electrocardiogram | Office | 103 | 100 | $51.77 | $5,332 |
| 99211 Office E&M - Established | Office | 83 | 21 | $17.23 | $1,430 |
| 99223 Hospital E&M - Initial | Facility | 69 | 61 | $137.38 | $9,479 |
By year: 2022 $367K for 5,201 services; 2023 $289K for 4,375 services; 2024 $438K for 5,049 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85610 Clinical Chemistry | 106 | 11 | $4.20 | $445 |
| 36415 Venipuncture Blood Collection | 14 | 14 | $8.65 | $121 |
Medicare prescription drug claims, 2024
In 2024, the drug Gerard Abreo prescribed most often to Medicare patients was Metoprolol Succinate, with 668 prescriptions and refills. In total Gerard Abreo wrote 7,653 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Metoprolol Succinate Generic | 668 | 1,914 | 207 | $12K |
| Eliquis Apixaban | 534 | 1,143 | 140 | $645K |
| Amlodipine Besylate Generic | 458 | 1,316 | 163 | $3,017 |
| Atorvastatin Calcium Generic | 431 | 1,241 | 130 | $3,953 |
| Nebivolol Hcl Generic | 425 | 1,144 | 132 | $23K |
| Olmesartan-Hydrochlorothiazide Olmesartan/Hydrochlorothiazide | 395 | 1,053 | 140 | $14K |
| Xarelto Rivaroxaban | 344 | 775 | 95 | $409K |
| Metoprolol Tartrate Generic | 253 | 730 | 85 | $2,125 |
| Amiodarone Hcl Generic | 219 | 618 | 88 | $5,678 |
| Olmesartan Medoxomil Generic | 210 | 578 | 70 | $5,023 |
| Rosuvastatin Calcium Generic | 204 | 599 | 66 | $2,759 |
| Losartan Potassium Generic | 192 | 536 | 61 | $1,639 |
| Spironolactone-Hctz Spironolact/Hydrochlorothiazid | 166 | 454 | 58 | $5,961 |
| Olmesartan-Amlodipine-Hctz Olmesartan/Amlodipin/Hcthiazid | 165 | 394 | 42 | $20K |
| Nifedipine Er Nifedipine | 164 | 427 | 54 | $4,935 |
Brand drugs: 1,605 claims; generic drugs: 6,048 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Gerard Abreo $2,189 ($2,189 in general payments such as food, travel and fees) from 20 companies. The largest payer was Scpharmaceuticals Inc. with $283.
| Company | Payments | Amount |
|---|---|---|
| Scpharmaceuticals Inc. SCPH | 12 | $283 |
| Merck Sharp & Dohme LLC MRK | 10 | $258 |
| Novartis Pharmaceuticals Corporation NVS | 14 | $248 |
| Actelion Pharmaceuticals US, Inc. JNJ | 6 | $186 |
| E.R. Squibb & Sons, L.L.C. BMY | 11 | $181 |
| Novo Nordisk Inc NVO | 7 | $165 |
| Abiomed JNJ | 5 | $162 |
| Amgen Inc. AMGN | 11 | $136 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $119 |
| AstraZeneca Pharmaceuticals LP AZN | 6 | $118 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.